Has Eltrombopag eliminated the need to use allogeneic HSCT in first line treatment of pediatric aplastic anemia?. (12th July 2021)

Record Type:: Journal Article
Title:: Has Eltrombopag eliminated the need to use allogeneic HSCT in first line treatment of pediatric aplastic anemia?. (12th July 2021)
Main Title:: Has Eltrombopag eliminated the need to use allogeneic HSCT in first line treatment of pediatric aplastic anemia?
Authors:: Huan Ng, Chia
Jang-Milligan, Fraser
Schultz, Kirk R.
Abstract:
Is Part Of:: Pediatric hematology and oncology. Volume 38:Number 5(2021)
Journal:: Pediatric hematology and oncology
Issue:: Volume 38:Number 5(2021)
Issue Display:: Volume 38, Issue 5 (2021)
Year:: 2021
Volume:: 38
Issue:: 5
Issue Sort Value:: 2021-0038-0005-0000
Page Start:: 417
Page End:: 419
Publication Date:: 2021-07-12
Subjects:: Pediatric hematology -- Periodicals
Tumors in children -- Periodicals
Blood -- Diseases -- Periodicals
Hematologic Diseases -- Child
Hematologic Diseases -- Infant
Neoplasms -- Child
618.9215
Journal URLs:: http://informahealthcare.com/loi/pho ↗
http://informahealthcare.com ↗
DOI:: 10.1080/08880018.2021.1940579 ↗
Languages:: English
ISSNs:: 0888-0018
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 6417.599500
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:: 24997.xml